Skip to content

A Comparative Clinical Study to Assess the Accuracy of TensorTip MTX, a Non Invasive Device

A Comparative Clinical Study to Assess the Accuracy of TensorTip MTX, a Non Invasive Device for the Measurement of Physiological and Hematological Parameters

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02766010
Enrollment
48
Registered
2016-05-09
Start date
2016-05-22
Completion date
2016-08-29
Last updated
2020-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Brief summary

1. Aim- This study is aimed to access the accuracy of TensorTip MTX device measuring Hemoglobin A1C, Oxygen Concentration and Saturation ,Carbon Dioxide, Blood pH, Hemoglobin, Hematocrit, Red Cells Count, platelets, Blood Urea Nitrogen, Sodium, Potassium, Chloride, total bilirubin, cholesterol (HDL, LDL), Serum Creatinine, Peripheral Pulse Rate, Blood Pressure, Mean Arterial Pressure, cardiac output, cardiac index, stoke volume and blood gases compared with the simultaneous results from hospital references device (when available) 2. Hypothesis- Human physiological biomarkers may be measured from the color distribution of the internal or external (skin) tissue. The technology of the TensorTip device is based on the color distribution of the peripheral blood tissue, which enables the measurement of certain biomarkers and vital signs under consideration

Detailed description

1. This is a comparative clinical trial in which the measurements obtained by the TensorTip device will be compared with those obtained by the reference devices used by the hospital on daily or periodic monitoring (the devices will be identified by name and version at the final report). 2. Eligible real time color signal obtained by the TensorTip during the measurement shall be recorded simultaneously with the measurements obtained by the reference devices (as described in the above point).

Interventions

DEVICETensorTip

Non Invasive screening of various physiological and hematological parameters.

Sponsors

Cnoga Medical Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Male or female, age \> 18 2. Agree to sign voluntary inform consent.

Exclusion criteria

1. Refusal to sign an informed consent and to participate in the study. 2. Below the age of 18. 3. Finger size not suitable for the measurement chamber. 4. Injured skin in the measurement site. 5. Long fingernails

Design outcomes

Primary

MeasureTime frame
blood pressure measurement of the TensorTip against hospital readings3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026